Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Appetite suppression versus metabolic enhancement

GLP-1 agonists work primarily through appetite suppression, making caloric restriction feel natural. Users eat less because they want less food, not because they're forcing restriction. This experience differs fundamentally from traditional dieting. Growth hor

This comparison does not assign a generated winner or score.

  • GLP-1 agonists work primarily through appetite suppression, making caloric restriction feel natural. Users eat less because they want less food, not because they're forcing restriction. This experience differs fundamentally from traditional dieting.
  • Growth hormone approaches enhance metabolic rate and fat oxidation without significantly affecting appetite. Users may eat normally while experiencing improved fat utilization. This approach requires more dietary discipline but avoids appetite-related side effects.
  • Fat-specific fragments like AOD-9604 fall between these extremes, enhancing fat metabolism without appetite effects. Dietary choices remain entirely user-driven, for better or worse. Those with strong dietary discipline may prefer this approach.
More references

Related material

Comparison

Speed versus sustainability

GLP-1 agonists produce relatively rapid fat loss, often 1-2+ pounds weekly during active treatment. This pace motivates continued adherence but raises questions about long-term ma…

View details →
Comparison

AOD 9604 vs CJC 1295

Which peptide is better for you? Choosing between AOD 9604 vs CJC 1295 for fat loss may require a medical evaluation. A health professional will evaluate your hormone levels and m…

View details →